Vir Biotechnology, Inc.
VIR
$10.80
-$0.39-3.44%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 532.73M | 476.30M | 467.02M | 506.51M | 606.02M |
| Total Receivables | 5.60M | 3.30M | 3.60M | 4.00M | 5.20M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 33.48M | 41.46M | 41.54M | 32.96M | 36.27M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.93M | 1.93M | 1.92M | 2.22M | 88.22M |
| Total Current Assets | 573.74M | 522.99M | 514.08M | 545.68M | 735.71M |
|
|
|||||
| Total Current Assets | 573.74M | 522.99M | 514.08M | 545.68M | 735.71M |
| Net Property, Plant & Equipment | 109.82M | 113.92M | 117.72M | 121.76M | 125.65M |
| Long-term Investments | 16.94M | 16.94M | 16.94M | 16.94M | 16.94M |
| Goodwill | 16.94M | 16.94M | 16.94M | 16.94M | 16.94M |
| Total Other Intangibles | 7.70M | 7.78M | 7.85M | 7.92M | 8.00M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 31.59M | 31.00M | 31.66M | 22.94M | 20.14M |
| Total Assets | 1.21B | 1.03B | 1.00B | 1.02B | 1.19B |
|
|
|||||
| Total Accounts Payable | 17.75M | 5.45M | 9.80M | 6.85M | 12.23M |
| Total Accrued Expenses | 66.24M | 57.34M | 72.39M | 57.30M | 62.72M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.14M | 8.94M | 8.80M | 8.96M | 8.83M |
| Total Finance Division Other Current Liabilities | 1.83M | 1.83M | 1.83M | 2.12M | 21.23M |
| Total Other Current Liabilities | 1.83M | 1.83M | 1.83M | 2.12M | 21.23M |
| Total Current Liabilities | 94.96M | 73.56M | 92.82M | 75.22M | 105.00M |
|
|
|||||
| Total Current Liabilities | 94.96M | 73.56M | 92.82M | 75.22M | 105.00M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 84.14M | 86.64M | 89.05M | 91.22M | 93.41M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 53.22M | 52.63M | 55.68M | 56.92M | 46.65M |
| Total Liabilities | 232.31M | 212.82M | 237.55M | 223.36M | 245.06M |
|
|
|||||
| Common Stock & APIC | 2.23B | 2.14B | 1.97B | 1.95B | 1.94B |
| Retained Earnings | -1.24B | -1.32B | -1.20B | -1.15B | -991.71M |
| Treasury Stock & Other | -4.60M | -3.48M | -2.06M | -1.91M | -2.22M |
| Total Common Equity | 982.49M | 812.77M | 765.28M | 796.10M | 947.47M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 982.49M | 812.77M | 765.28M | 796.10M | 947.47M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 982.49M | 812.77M | 765.28M | 796.10M | 947.47M |
|
|
|||||